Originalspråk | engelska |
---|---|
Tidskrift | Blood |
Volym | 116 |
Utgåva | 21 |
Sidor (från-till) | 1281-1281 |
Antal sidor | 1 |
ISSN | 0006-4971 |
Status | Publicerad - 19 nov 2010 |
Evenemang | 52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando Varaktighet: 4 dec 2010 → 7 dec 2010 |
Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.
Satu Koivula, Minna Taskinen, Ping Chen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppa
Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review